Actively Recruiting
Sleep and Morning Wellbeing Study
Led by Athletic Greens International · Updated on 2026-02-11
300
Participants Needed
1
Research Sites
18 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The study will be a prospective randomized, controlled clinical study. There will be interventional treatment for a total of 30 days. The subjects will complete questionnaires throughout the study at pre-specified timepoints.
CONDITIONS
Official Title
Sleep and Morning Wellbeing Study
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Male or female.
- Age 25-59 years.
- Body mass index between 18.5 and 29.9 kg/m2.
- Currently experiencing problems with sleep quality, falling asleep, staying asleep, or waking during the night.
- RU-SATED score of 17 or less.
- Willing and able to follow the study protocol.
- Willing to stop using other sleep-related supplements, medications, herbal remedies, or over-the-counter sleep aids during the study.
- Agree to limit alcohol intake within about 4 hours of bedtime during the study.
- Agree to limit caffeine intake to 400 mg per day and avoid caffeine after 2:00 PM during the study.
- Generally healthy without uncontrolled chronic diseases.
- Living in the United States.
- Agree to stop restricted products and complete all study assessments.
You will not qualify if you...
- Diagnosed chronic sleep conditions such as insomnia, narcolepsy, REM Behavior Disorder, moderate to severe restless leg syndrome, or sleep apnea.
- Current use of sleep-tracking devices or apps that might affect sleep behavior or perception.
- Women in perimenopause or experiencing vasomotor symptoms like night sweats.
- Use of hormone therapy in the past 3 months.
- Diagnosed psychiatric disorders including major depressive disorder with acute symptoms, bipolar disorder, generalized anxiety disorder with active symptoms, or PTSD with frequent nightmares.
- Diagnosed neurodegenerative or chronic pain disorders including Parkinson's disease, Alzheimer's disease, or uncontrolled fibromyalgia.
- Regular prescribed stimulant use such as amphetamines or modafinil.
- Current use of certain antidepressants activating the central nervous system.
- Use of cannabis or THC-containing products within the past 30 days.
- Employment involving night shifts, rotating shifts, or excessive travel disrupting sleep.
- Current use of prescription sleep aids.
- Starting new sleep-related supplements or medications during the study.
- Use of sedative products within 4 weeks prior to enrollment or frequent habitual use unless approved.
- Allergy or sensitivity to study product ingredients.
- Pregnant, breastfeeding, or trying to conceive during the study.
- History of substance abuse.
- Heavy alcohol use (8 or more drinks/week for women, 15 or more for men).
- Participation in another research study now or within the next 7 weeks.
- Any condition or behavior that may interfere with study participation or data integrity as judged by the investigator.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Alethios (Virtual Study Platform)
San Francisco, California, United States, 94117
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here